)
Edge
Extra Everything: The Story of Chipotle
Chipotle's story from a single restaurant to a nationwide chain, through crisis and turnaround, built on one of the strongest models in the industry.
Pharmaids Pharmaceuticals
Pharmaids Pharmaceuticals (524572) investor relations material
Pharmaids Pharmaceuticals Q4 25/26 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 25/26 earnings summary29 May, 2026
Executive summary
Audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, were approved, with unmodified audit opinions from statutory auditors.
The group operates in a single segment: Contract Research and Manufacturing Services.
A corporate guarantee of up to Rs. 75 lakhs was approved for a material subsidiary under the Emergency Credit Line Guarantee Scheme (ECLGS) 5.0.
Financial highlights
Standalone revenue from operations for FY26 was Rs. 1,060.25 lakhs, up from Rs. 234.09 lakhs in FY25; consolidated revenue was Rs. 2,788.24 lakhs, up from Rs. 1,944.74 lakhs year-over-year.
Standalone net loss for FY26 was Rs. (1,043.72) lakhs, compared to Rs. (727.92) lakhs in FY25; consolidated net loss was Rs. (1,157.19) lakhs, compared to Rs. (1,350.51) lakhs in FY25.
Standalone EPS for FY26 was Rs. (2.95) vs. Rs. (2.06) in FY25; consolidated EPS was Rs. (3.31) vs. Rs. (3.05) in FY25.
Total standalone assets as of March 31, 2026, were Rs. 8,396.00 lakhs; consolidated assets were Rs. 8,726.21 lakhs.
Outlook and guidance
No explicit forward-looking guidance provided; management continues to focus on contract research and manufacturing services.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Pharmaids Pharmaceuticals
- Quarterly consolidated net loss of Rs. 264.60 lakhs on revenue of Rs. 543 lakhs; lease discontinued.524572
Q3 25/2612 Feb 2026 - Q2 and H1 FY25 results reflect ongoing losses and negative cash flows amid sector focus.524572Q2 24/2521 Nov 2025
- Losses persist despite higher standalone revenue; consolidated revenue declines year-over-year.524572Q1 24/2521 Nov 2025
- Losses narrowed on higher revenue, with major disinvestment and debt repayment completed.524572Q2 25/2611 Nov 2025
- Q1 FY26 saw higher losses and a pending major divestment, with no impact on current results.524572Q1 25/2611 Aug 2025
- Revenue growth offset by higher losses and increased investments in FY25.524572Q4 24/256 Jun 2025
- Revenue up but losses deepen; asset sale and capital moves mark strategic shift.524572Q3 24/256 Jun 2025
Next Pharmaids Pharmaceuticals earnings date
Q1 26/2710 Aug, 2026
Pharmaids Pharmaceuticals
Next Pharmaids Pharmaceuticals earnings date
Q1 26/2710 Aug, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
)
Frequently asked questions
Explore our global coverage